Xeroderma and drugs of ingredients of amlodipine besylate; hydrochlorothiazide; olmesartan medoxomil - a phase IV clinical study of FDA data
There is no Xeroderma reported by people who take drugs with ingredients of amlodipine besylate; hydrochlorothiazide; olmesartan medoxomil yet. This review analyzes which people have Xeroderma with drugs with ingredients of amlodipine besylate; hydrochlorothiazide; olmesartan medoxomil. It is created by eHealthMe based on reports from the FDA, and is updated regularly.
Drug(s) considered in the study (i.e. both brand name and generic drugs): Olmesartan medoxomil, amlodipine and hydrochlorothiazide, Tribenzor.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No report is found.
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Drugs with ingredients of amlodipine besylate; hydrochlorothiazide; olmesartan medoxomil, their effectiveness, alternatives and more:
How the study uses the data?
The study uses data from the FDA. It is based on amlodipine besylate; hydrochlorothiazide; olmesartan medoxomil. All drugs that have the same active ingredients (e.g. brand name and generic drugs) are considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- St. John'S Wort and Darvocet drug interaction - a second ago
- Macrobid and Lipoic Acid drug interaction - a second ago
- Botox and Ibu drug interaction - 9 seconds ago
- Solu-Medrol and Amlodipine drug interaction - 15 seconds ago
- Pantoprazole Sodium and Lotensin drug interaction - 47 seconds ago
- Coreg and Incoherent - 53 seconds ago
- Fosamax and Valcyte drug interaction - a minute ago
- Diltiazem Hydrochloride and Aortic Thrombosis - a minute ago
- Hydrocodone Bitartrate And Acetaminophen and Respiratory Distress - a minute ago
- Ditropan and Fainting - a minute ago